SLC2A5 and cancer: Additional studies have shown that the absence of ChREBP affects the expression of intestinal GLUT5, reducing fructose absorption and metabolism, and increasing the concentration of unmetabolized fructose in the gut, which may enhance the survival and proliferation of cancer cells, further emphasizing the significant role fructose may play in cancer progression 115.